Rule 1: A molecule containing a benzene ring is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 2: A molecule containing a chlorine atom is likely to cause adverse effects related to respiratory and cardiovascular disorders.
Rule 3: A molecule containing a nitro group is likely to cause adverse effects related to genotoxicity and carcinogenicity.
Rule 4: A molecule containing a carboxylic acid group tends to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 5: If a molecule contains a halogenated aromatic ring, it may cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 6: If a molecule contains a nitrogen-containing heterocycle, it may cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 7: The presence of a halogen atom in a molecule (such as -Cl, -Br, -I) is likely to cause adverse effects related to skin and eye disorders.
Rule 8: If a molecule contains a sulfonamide group, it might cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 9: Molecules with functional groups like chloride are more likely to cause adverse effects related to respiratory and cardiovascular disorders.
Rule 10: Molecules with functional groups like a nitro group tend to cause adverse effects related to neurological and psychiatric disorders.
Rule 11: If a molecule contains a carbonyl group, it is likely to cause adverse effects related to respiratory and cardiovascular disorders.
Rule 12: If a molecule contains a nitrogen atom, it is likely to cause adverse effects related to neurological and psychiatric disorders.
Rule 13: If a molecule contains a phosphorus atom in its structure, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 14: If a molecule contains both a carboxylic acid group and a nitrogen-containing heterocycle, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 15: If a molecule contains a carbonyl group (C=O) and a sulfur atom, it tends to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 16: Molecules containing a phosphate group likely cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 17: If a molecule contains both a carboxylic acid group (-COOH) and a nitro group (-NO2), it is less likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 18: If a molecule contains a functional group like a sulfoxide group, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 2: If a molecule contains a functional group such as a chloride, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 4: If the molecule contains a halogenated aromatic ring, it is less likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 5: If the molecule contains a halogen atom (-Cl), which is known to cause adverse effects related to skin and eye disorders.
Rule 6: If the molecule contains a functional group such as a sulfonamide group, it is more likely to cause adverse effects related to gastrointestinal disorders.
Rule 7: If the molecule contains a tertiary amine group (-N(CH3)3), it is likely to cause adverse effects related to cardiovascular disorders.
Rule 8: The presence of a nitro group in a molecule increases the likelihood of causing adverse effects related to musculoskeletal and connective tissue disorders.
Rule 9: The presence of a carbonyl group in a molecule increases the likelihood of causing adverse effects related to musculoskeletal and connective tissue disorders.
Rule 10: If the molecule contains a gadolinium ion (Gd+3), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 11: If the molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 12: If the molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to musculoskeletal and connective tissue disorders.
Rule 13: The presence of a chlorine atom in a molecule increases the likelihood of causing adverse effects related to musculoskeletal and connective tissue disorders.
Rule 14: The presence of a sulfur atom in a molecule increases the likelihood of causing adverse effects related to musculoskeletal and connective tissue disorders.
